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Edited by Barry HalliwellAbstract Peroxiredoxin 5 is a thioredoxin peroxidase ubiqui-
tously expressed in mammalian tissues. Peroxiredoxin 5 can be
addressed intracellularly to mitochondria, peroxisomes, the cyto-
sol and the nucleus. Here, we show that mitochondrial human
peroxiredoxin 5 protects mitochondrial DNA (mtDNA) from
oxidative attacks. In an acellular assay, recombinant peroxire-
doxin 5 was shown to protect plasmid DNA from damages in-
duced by metal-catalyzed generation of reactive oxygen
species. In Chinese hamster ovary cells, overexpression of mito-
chondrial peroxiredoxin 5 signiﬁcantly decreased mtDNA dam-
ages caused by exogenously added hydrogen peroxide.
Altogether our results suggest that mitochondrial peroxiredoxin
5 may play an important role in mitochondrial genome stability.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Because of its close proximity to the electron transport
chain, mitochondrial DNA (mtDNA) is highly exposed to
oxidative attacks caused by reactive oxygen species (ROS)
produced by electron leakage during oxidative phosphoryla-
tion [1]. Moreover, mtDNA is thought to be more suscepti-
ble to oxidative damages than nuclear DNA (nDNA) due to
the lack of histones [2,3] and the vulnerability or the insuﬃ-
ciency of mitochondrial repair pathways [4,5]. Importantly,
oxidative damage to mtDNA is now emerging as an etiolog-
ical factor in oxidative stress-related disorders such as car-
diovascular diseases, neurodegenerative diseases but also
normal aging [6].Abbreviations: C47S-PRDX5, recombinant C47S mutant of human
PRDX5; CCC, supercoiled plasmid DNA; CHO cells, Chinese hamster
ovary cells; COX1, cytochrome C oxidase subunit 1; DTT, dithiothre-
itol; H2O2, hydrogen peroxide; MFO, thiol/Fe
3+/O2 mixed-function
oxidase; mtDNA, mitochondrial DNA; ND4, NADH dehydrogenase
subunit 4 gene; nDNA, nuclear DNA; NLS, nuclear localization sig-
nal; nuc-PRDX5, nuclear human recombinant PRDX5; OC, open
circular plasmid DNA; OH, hydroxyl radical; PRDX, peroxiredoxin;
ROS, reactive oxygen species; tBHP, tert-butylhydroperoxide; wt-
PRDX5, wild-type human recombinant PRDX5
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doi:10.1016/j.febslet.2005.03.027In addition to well documented antioxidant enzymes such as
superoxide dismutases, catalase and gluthatione peroxidases, a
family of peroxidases named peroxiredoxins (PRDXs) has
been discovered more than a decade ago (for review see [7]).
PRDXs are a superfamily of selenium-free and heme-free per-
oxidases able to catalyze the reduction of hydrogen peroxide,
alkyl hydroperoxides and peroxynitrite [8–10]. In mammals,
six PRDX isoforms (PRDX1–6) encoded by six diﬀerent genes
have been identiﬁed and characterized. PRDX3 and PRDX5
are the two mammalian PRDXs that are addressed to mito-
chondria [11,12]. Moreover, PRDX5 can be also addressed
to peroxisomes, the cytosol and, to a lesser extent, to the nu-
cleus [13].
Recently, we showed that overexpression of human PRDX5
in the nucleus of Chinese hamster ovary (CHO) cells decreases
nDNA damages induced by exogenously applied peroxides
[13]. Furthermore, peroxiredoxin-null yeast cells have been re-
ported to display an increased rate of spontaneous nDNA
mutations [14] and TSA1, a Saccharomyces cerevisiae peroxire-
doxin, was found to play a signiﬁcant role in suppression of
nDNA mutations [15]. Moreover, it appears that in many
mammalian cell types, PRDX5 is primarily addressed to mito-
chondria [11,16–18]. In view of this, the purpose of the current
study was to further characterize the mitochondrial genopro-
tective function of mitochondrial PRDX5. First, using an acel-
lular system composed of plasmid DNA, which resembles the
structure of mtDNA, we investigated the protective eﬀects of
human recombinant PRDX5 against DNA damages induced
by metal-catalyzed generation of ROS, the thiol/Fe3+/O2
mixed-function oxidase (MFO) system [19]. Second, the geno-
protective properties of PRDX5 on mtDNA were examined in
CHO cells overexpressing mitochondrial PRDX5 and exposed
to exogenously added peroxides.2. Materials and methods
2.1. Materials
Hydrogen peroxide (H2O2), tert-butylhydroperoxide (tBHP) and
ethidium bromide were purchased from Sigma. The BCA protein assay
reagent was from Pierce. Fetal bovine serum, Dulbeccos modiﬁed Ea-
gles media (DMEM), penicillin, streptomycin, L-glutamine and tryp-
sin-EDTA were purchased from Life Technologies, Inc. All primers
were obtained from Invitrogen. FeCl3 was from Aldrich, DL-dithio-
threitol (DTT) from Acros and Chelex-100 resin from Bio-Rad.
2.2. Expression and puriﬁcation of recombinant proteins
Human PRDX5 [11] (GenBank Accession No. NM_012094), the
short form without its mitochondrial pre-sequence, was expressed in
Escherichia coli strain M15 (pRep4) as 6 ·His-tagged protein usingblished by Elsevier B.V. All rights reserved.
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Fig. 1. Schematic representation of mitochondrial DNA of Cricetulus
griseus and sequences ampliﬁed by PCR. The organization of the
mitochondrial genome being very well conserved in rodents, the
partially known C. griseus mitochondrial genome was represented
according to the organization of the Mus musculus mitochondrial
DNA. Partially sequenced coding sequences, tRNA and rRNA
sequences are shown as white boxes. Complete coding sequences and
tRNA sequences are shown as grey boxes. The 8.1 kbp long PCR
ampliﬁcation product is represented as a large arc. The 100 bp real-
time PCR product is also represented. An asterisk indicates the
TaqMan probe. The four primers used for PCR ampliﬁcation are
indicated by arrows (see also Section 2).
2328 I. Banmeyer et al. / FEBS Letters 579 (2005) 2327–2333pQE-30 expression vector (Qiagen) and puriﬁed as described previ-
ously (wt-PRDX5) [20]. The mutated recombinant PRDX5 (C47S-
PRDX5), in which the N-terminal catalytic Cys47 of the short form
(amino acid numbering refers to mature protein) was replaced by a ser-
ine, was generated by standard PCR-mediated site-directed mutagene-
sis as reported in Plaisant et al. [21]. To produce a nuclear recombinant
PRDX5 (nuc-PRDX5) [13] corresponding to the short form of
PRDX5 in N-terminal fusion with the SV40 large-T antigen nuclear
localization sequence, we ampliﬁed nuc-PRDX5 DNA [13] by PCR
using forward primer 5 0-ACT AGT GGA TCC GGG CCA AAG
AAG AAG CGA AAG-30 (BamHI site underlined) and reverse primer
5 0-GTC GCA AGC TTG CCT CAG AGC TGT GAG ATG-3 0 (Hin-
dIII site underlined). The PCR product was digested with BamHI and
HindIII, and ligated into the pQE-30 expression vector. The insert was
sequenced and the additional N-terminal fusion with the 6 · His-tag
was conﬁrmed. The resulting vector was used to transform E. coli
strain M15 (pRep4) and nuc-PRDX5 was puriﬁed as described previ-
ously [20].
2.3. Protection assay against oxidative single-strand breaks of plasmid
DNA
pBR322 plasmid DNA (0.5 lg) was mixed with freshly prepared
DTT (10 mM), FeCl3 (3 lM) (MFO system) and recombinant human
PRDX5 in a total volume of 20 ll of 50 mM HEPES (pH 7.0). Reac-
tion mixtures (Chelex-100-eluted distilled water) were incubated for
90 min at 37 C. Reactions were terminated by the addition of 4 ll
of electrophoresis loading buﬀer. DNA samples were applied to 0.8%
agarose gels in a TBE buﬀer and electrophoresis was performed at
100 mV for 1.5 h, at room temperature. After electrophoresis, the gel
was stained with ethidium bromide, visualized under UV light and
photographed. Quantitation was made by densitometric analyzes of
the intensity of the bands using Kodak 1DV.3.5.3 software (Kodak
Scientiﬁc Imaging Systems).
2.4. Cell culture
We used our previously established mito-PRDX5 CHO clone that
stably overexpress human PRDX5 in mitochondria and the corre-
sponding control cells (control CHO clone) which had been transfected
with the expression vector without insert [13]. CHO-K1 cells were cul-
tured in DMEM, 4.5 g D-glucose/l, supplemented with 10% fetal bo-
vine serum, 100 U/ml penicillin, and 100 lg/ml streptomycin
(complete DMEM) in a 95% humidiﬁed atmosphere, in 5% CO2 at
37 C. Overexpression of PRDX5 and mitochondrial localization in
CHO cells was veriﬁed by immunoﬂuorescence as previously described
[11,13], using rabbit anti-human PRDX5 polyclonal antibody [22] and
mouse monoclonal antibody directed to cytochrome C oxidase subunit
1 (COX1) (Molecular Probes).
2.5. Cell treatment with H2O2 and tBHP
1 · 106 CHO cells were seeded into 75 cm2 culture ﬂasks in complete
DMEM. After 15–18 h of culture, 80% conﬂuent cells were exposed to
indicated concentrations of peroxide during one hour in DMEM with-
out phenol red (4.5 g D-glucose/l) supplemented with 100 U/ml penicil-
lin, 100 lg/ml streptomycin and 292 mg/l of L-glutamine (37 C, 95%
humidity, 5% CO2). After treatment, cells were washed with PBS, har-
vested by trypsinisation and frozen at 80 C until the isolation of to-
tal DNA.
2.6. Isolation of total DNA
High molecular weight DNA was isolated with the Dneasy Tissue
Kit (Qiagen) as described by the manufacturer. The concentration of
total cellular DNA was determined by DAPI ﬂuorescence (exc.
370 nm and em. 460 nm). DNA samples were distributed into aliquots
and frozen at 20 C to avoid repeated freezing/thawing cycles.2.7. Detection of oxidative mtDNA damages
Long PCR ampliﬁcation of mtDNA was performed in a GeneAmp
PCR system 2400 (Perkin–Elmer). Reaction mixtures contained 80 ng
of total DNA, 2.75 mM MgCl2, 500 lM deoxynucleotide triphos-
phates, 0.4 lM primers and 1.68 units of Expand Long Template poly-
merase (Roche) in a ﬁnal volume of 20 ll. The primer nucleotide
sequences were (see also Fig. 1): forward primer 5 0-GGC TTA CAA
GAT GCT ACG TCA CC-30 (primer A), ﬂanking the region of thecytochrome c oxidase subunit II gene (GenBank Accession No.
AF455051) and reverse primer 5 0-GGT AGG GTG GCT AGG
ATT AGG ATG G-3 0 (primer B), ﬂanking the region of the cyto-
chrome b gene (GenBank Accession No. AB033693). Prior to Expand
Long Template polymerase addition, a hot start protocol was carried
out that consisted of an initial cycle of 94 C for 2 min and 80 C for
2 min to ensure complete strand separation. The thermocycler proﬁle
included 30 cycles at 94 C for 1 min, 64 C for 1 min, 68 C for
12 min, and ﬁnal extension at 68 C for 12 min. After long ampliﬁca-
tion, samples were diluted 100· and frozen at 20 C until quantita-
tion by real-time PCR. Quantitative real-time PCR was performed
on the GeneAmp 7000 (ABI-PRISM), with the following primers
(Fig. 1) hybridizing on NADH dehydrogenase subunit 4 gene (ND4;
GenBank Accession No. NM_012094): forward primer 5 0-CAC
GAT AGC TAA GAT CCA AAC TGG G-3 0 (primer C) and reverse
primer 5 0-GCC CAT TAC TTC CCA TCC CAT AGG C-3 0 (primer
D). The following TaqMan probe (Applied Biosystems), labelled with
5 0-FAM and 3 0-TAMRA was used: 5 0-CGC TCA TGG TCT TAC
ATC TTC TCT ACT ATT TTG TCT TGC-3 0. PCR ampliﬁcations
were carried out in TaqMan Universal PCR Master Mix (Applied Bio-
systems) with 0.2 ng DNA, 0.3 lM primers and 0.15 lM TaqMan
probe in a ﬁnal volume of 25 ll. To express the results in lesions per
large PCR fragment, derived from the Poisson equation as described
in Santos et al. [23], the threshold cycle values were plotted against
the logarithm of DNA amounts for a series of known input templates
and the DNA quantities of the unknown template were determined by
linear regression.3. Results and discussion
3.1. Protective eﬀects of PRDX5 against oxidative single-strand
breaks of plasmid DNA
We investigated whether PRDX5 can directly protect DNA
from single-strand breaks caused by metal catalyzed genera-
tion of ROS. In the MFO system, autoxidation of thiols
(DTT) in the presence of iron generates ROS such as superox-
Fig. 2. Protective eﬀects of diﬀerent recombinant PRDX5 on DNA
strand breaks induced by the MFO system. Protective eﬀects of human
wt-PRDX5 (A), nuc-PRDX5 (B), C47S-PRDX5 (C) at diﬀerent
concentrations. (D) Quantitation of the protection conferred by the
diﬀerent recombinant PRDX5 proteins against DNA strand breaks
induced by the MFO system. Results are expressed as the percentage of
plasmid open circular form (OC) on total plasmid DNA (OC + CCC).
Values are means ± S.E.M. of results from ﬁve replicates in each case.
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OH) [24]. When gener-
ated very close to the nucleic acid molecule, hydroxyl radical
can add hydrogen atoms to DNA bases or abstract hydrogen
atoms from the sugar moiety, producing modiﬁed bases, DNA
strand breaks or abasic sites [25]. Induction of single-strand
breaks into supercoiled plasmid DNA (CCC DNA) leads to
the formation of open circular plasmid DNA (OC DNA).
Accordingly, DNA damages can be assessed by measuring
the percentage of OC DNA on CCC DNA. As shown in
Fig. 2A, incubation of plasmid DNA with the MFO system in-
creased the formation of OC DNA. The addition of wt-
PRDX5 resulted in an inhibition of the conversion of CCC
to OC DNA in a dose-dependent manner. Wt-PRDX5 at
2 lM (36.6 lg/ml) or greater, completely protected plasmid
DNA from the MFO system (Figs. 2A and D). Interestingly,
TSA1, a yeast peroxiredoxin, was also tested for its DNA pro-
tective eﬀects in similar conditions by Kwon and collaborators
[19]. Complete DNA protection of TSA1 was observed from
3.7 lM (80 lg/ml), suggesting that wt-PRDX5 displays higher
genoprotective properties.
Afterwards, we investigated whether recombinant nuc-
PRDX5 can also directly protect DNA from damages induced
by the MFO system (Figs. 2B and D). Indeed, this N-terminal-
modiﬁed PRDX5, which allows a high expression of PRDX5
in the nucleus, was shown to protect nDNA against H2O2
and tBHP in CHO cells [13]. In the acellular assay, at 0.25
and 0.5 lM, nuc-PRDX5 inhibits the conversion of CCC to
OC DNA similarly to wt-PRDX5 at the same concentrations
(Figs. 2B and D). However, higher concentrations of nuc-
PRDX5 produced migration anomalies. Indeed, at 1 lM, OC
and CCC bands migrated slightly slower, while at 2–4 lM of
nuc-PRDX5, plasmid DNA appeared as a high molecular
weight smear (Fig. 2B). This modiﬁed DNA pattern concealed
the genoprotective eﬀects of nuc-PRDX5 at higher concentra-
tions. The same DNA pattern of migration was observed in
absence of the MFO system from 1 to 4 lM of nuc-PRDX5
(not shown). This modiﬁed migration pattern probably results
from electrostatic interactions between the nuclear localization
signal (NLS) lysine-rich amino acids and plasmid DNA, com-
pacting the DNA and forming stable protein-DNA polyplexes
when high protein concentrations of nuc-PRDX5 were used
[26,27]. Finally, the genoprotective eﬀects of wt- and nuc-
PRDX5 were very similar at least at low protein concentra-
tions. These results are reinforced by the fact that wt- and
nuc-PRDX5 exhibited identical peroxidatic activities, in the
presence of DTT or the thioredoxin system and in the presence
of tBHP or H2O2 (not shown). All these results conﬁrm that
fusion of NLS at the amino-terminus of PRDX5 did not mod-
ify the catalytic properties of PRDX5. As a negative control,
we used the catalytic mutant C47S-PRDX5, which is com-
pletely devoid of peroxidatic activities [16,21]. As shown in
Figs 2C and D, this mutant exhibited a very limited DNA pro-
tection at the highest concentrations. This weak protection is
probably due to unspeciﬁc quenching of OH by high concen-
trations of any proteins, as the latest are also cleaved with the
MFO system [28].3.2. Genoprotective activities of PRDX5 on michondrial DNA
Long PCR ampliﬁcations of mtDNA were used to look for
signiﬁcant oxidative mtDNA damages in CHO cells. This
method oﬀers a broader measurement of the quality of theDNA, contrasting to more speciﬁc methods such as HPLC
coupled with electrochemical detection [29]. Oxidative DNA
damage, such as strand breaks, apurinic sites and some modi-
ﬁed bases (for example, 8-OxodA) can hamper the progress of
the polymerase [30,31]. So, a reduction in the relative yield of
the long PCR product reﬂects the presence of blocking DNA
lesions [23].
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step PCR. First, long mtDNA fragments of 8.1 kbp were
ampliﬁed by PCR using total DNA as template (Fig. 1).
PCR ampliﬁcation yield of such DNA fragments decreases
with increasing amount of lesions [23]. Thus, in a second step,
the yield of the long mtDNA PCR product was quantitated by
real-time PCR, using primers and TaqMan probe hybridizing
to ND4, localized in the middle of the long mtDNA PCR frag-
ment (Fig. 1). Our long PCR conditions allowed the method to
be quantitative. Indeed, a standard curve could be established
between DNA quantities used as template in the long PCR and
PCR amplicons detected by real-time PCR (Fig. 3). Results
were normalized by quantitating each sample for the amount
of initial mtDNA without previous long PCR ampliﬁcation
using the same real-time PCR conditions. As shown in Fig.
4, the decrease in the long PCR ampliﬁcation, reﬂecting in-R2 = 0.9853
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Fig. 3. Typical standard curve obtained by long PCR ampliﬁcation of
mtDNA and subsequent real-time PCR quantitation of ND4 mtDNA
with diﬀerent concentrations of total DNA of CHO cells. In the long
PCR ampliﬁcation of mtDNA (see Fig. 1 and Section 2), diﬀerent
concentrations of total DNA from CHO cells (4, 2 and 0.25 ng/ll) were
used. The products of long PCR ampliﬁcations were diluted 500-fold
before performing real-time PCR quantitation of ND4 mtDNA. This
dilution was required due to the very high sensitivity of real-time PCR
and to ensure a good linearity. Values are means ± S.E.M. of results
from two replicates in each case.
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Fig. 4. Representative real-time PCR ampliﬁcation curves of ND4
mtDNA after exposure of control CHO cells to diﬀerent concentra-
tions of H2O2. Curves 1 and 5: 0 mM H2O2; curves 2 and 6: 0.2 mM
H2O2; curves 3 and 7: 0.5 mM H2O2; curves 4 and 8: 1 mM H2O2.
Curves 1–4 were obtained with previous long PCR ampliﬁcation of
8.1 kbp mtDNA; curves 5–8 were obtained without previous long PCR
ampliﬁcation. Long and real-time PCR ampliﬁcations were performed
as described in Section 2. DRn is the baseline substracted PCR product
ﬂuorescence normalized to an internal dye (ROX).creased DNA lesions, appeared as a shift of the real-time
PCR ampliﬁcation curve to the right. By contrast, the real-
time PCR ampliﬁcation, without previous long PCR ampliﬁca-
tion, produced overlapping curves either with or without in-
duced DNA damages, given that similar amounts of mtDNA
quantities were used in the reaction.
To determine whether mitochondrial PRDX5 can protect
mtDNA against oxidative attacks, we submitted our previ-
ously established CHO clones overexpressing PRDX5 in mito-
chondria (mito-PRDX5 CHO) to exogenously applied H2O2
and tBHP for 1 h. Mito-PRDX5 CHO overexpressed human
PRDX5 in mitochondria, up to 3.4 fold as previously quanti-
tated by immunoblotting [13]. Co-localization of PRDX5 and
cytochrome C oxidase (Fig. 5) showed that PRDX5 is consti-
tutively localized to mitochondria in control CHO cells. Con-
stitutive expression of PRDX5 in mitochondria has also been
shown in other cell types, including HeLa cells, epithelial cells
of rat kidney and bovine embryonic cells [16–18].
With increasing concentrations of H2O2 up to 1 mM, an in-
crease of mtDNA damages was observed as measured by real-
time PCR (Fig. 6A). Maximal mtDNA damages appeared at
0.5 mM and above, with 6 lesions/8.1 kbp. At these concen-
trations, H2O2 prevented nearly totally the PCR ampliﬁcation
of mtDNA long fragments. Overexpressing PRDX5 in mito-
chondria of CHO cells signiﬁcantly reduced mtDNA damages
caused by exogenously added H2O2, completely at 0.2 mM and
partially at 0.5 and 1 mM H2O2. H2O2 has been reported to
damage mtDNA in many cell types. Indeed, Santos et al.
[30] showed that a one hour exposure of human ﬁbroblasts
to H2O2 induced persistent mtDNA lesions even after longFig. 5. Immunoﬂuorescence analysis of subcellular localization of
PRDX5 in CHO cells. Cultured control CHO cells transfected with
pEF-BOS vector without insert (Control CHO; A, B, C) or cells
transfected with pEF-BOS vector containing the cDNA sequence
coding for PRDX5 with its mitochondrial presequence (Mito-PRDX5
CHO; D, E, F) were processed for immunoﬂuorescence with antibod-
ies directed to PRDX5 (A, D) and mitochondrial COX1 (B, E).
Localization of PRDX5 in mitochondria either in control CHO or
PRDX5 overexpressing cells was conﬁrmed by co-localization of
PRDX5 with COX1 as illustrated in merged images (Merge; C, F).
Bar, 10 lM.
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Fig. 6. MtDNA damages caused by H2O2 (A) and tBHP (B) in control CHO cells and in CHO cells overexpressing mitochondrial PRDX5 (mito-
PRDX5 CHO). CHO cells were exposed to indicated concentrations of peroxides for 1 h. MtDNA damages were assessed by combined long PCR
ampliﬁcation and real-time PCR (see Section 2). Results are expressed as relative PCR ampliﬁcation of mtDNA of peroxides-exposed CHO cells to
corresponding unexposed controls. Results are also expressed in lesion frequency per large PCR fragment, derived from the Poisson equation as
described in Santos et al. [23]. Values are means ± S.E.M. of results from four replicates in each case. Signiﬁcance versus control is designated as
\p < 0.05 and \\p < 0.001 (Student t Test).
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by OH, resulting from Fenton reaction catalyzed by transition
metals. Mitochondria are tightly involved in iron traﬃcking,
due to synthesis of heme or Fe–S clusters [32]. Mitochondrial
electron transport proteins contain iron–sulfur centers and are
sensitive to ROS. Consequently, oxidative stress can liberate
those protein iron contents that can lead to increased genera-
tion of OH within the inner mitochondrial matrix [33]. Mito-
chondrial PRDX5 could directly protect mtDNA, by reducing
H2O2 and preventing the formation of
OH close to mtDNA.
PRDX5 could also indirectly protect mtDNA by maintaining
the integrity of the mitochondrial electron transport chain,
preventing the increased generation of OH within the inner
mitochondrial matrix. MtDNA lesions have been suggested
to be the initial event leading to a loss of mitochondrial mem-
brane potential, cell growth arrest and subsequent cell death
[30]. Besides, Yuan et al. [34] reported recently that cytosolic
overexpression of PRDX5 could aﬀord cell protection against
apoptosis induced by H2O2 in human tendon cells.
MtDNA damages induced by tBHP, a short chain analog of
lipid hydroperoxide, were also investigated in the present
study. tBHP at concentrations of 0.5 mM or above increased
mtDNA damages (Fig. 6B). However, these concentrations
produced lower range of mtDNA damages (2.7 lesions/
8.1 kbp) than those observed for H2O2 (5.7 lesions/
8.1 kbp), suggesting that the propensity of tBHP to induce
mtDNA damages is less important than for H2O2 in CHOcells. Restriction of the mitochondrial availability of suitable
iron species for tBHP to produce mtDNA damages could ex-
plain the lowest level of mtDNA damages. Indeed, Byrnes et
al. [35] reported that tBHP can react with a small subset of cell
iron species which react with H2O2 to subsequently generate
DNA strand breaks. To date, the nature of the iron species
able to react with tBHP and to induce DNA damages is not
fully characterized. As shown in Fig. 6B, overexpressing
PRDX5 in mitochondria could aﬀord more limited mtDNA
protection against tBHP than against H2O2. However, in our
previous study, mitochondrial overexpression of PRDX5 con-
ferred the highest cell protection against tBHP [13]. As
PRDX5 cannot aﬀord high mtDNA protection against tBHP,
increased cell survival probably resulted from PRDX5 protec-
tive eﬀect on other cellular targets, such as membrane protein
thiols. Indeed, tBHP can oxidize membrane protein thiols,
leading to membrane disruption, NADPH depletion and ﬁnal-
ly loss of cell viability [36,37]. Finally, our current results
strongly suggest that mtDNA is not a major target of tBHP
in CHO cells. As a matter of fact, very few studies reported
mtDNA damages induced by tBHP [38,39].3.3. Conclusions and perspectives
Recently, compelling evidence implicated peroxiredoxins in
genome maintenance [14]. Our previous studies showed geno-
protective eﬀects of PRDX5 on nDNA [13]. The present work
2332 I. Banmeyer et al. / FEBS Letters 579 (2005) 2327–2333demonstrates the protective eﬀects of mitochondrial PRDX5
on mtDNA in CHO cells. Considering its constitutive expres-
sion in mitochondria of many mammalian cell types [16–18,
this study] as well as its genoprotective properties [13] and con-
sidering its highly conserved mitochondrial targeting through-
out evolution [10,11,40], PRDX5 appears as a good candidate
to protect mtDNA against oxidative damages caused by exog-
enous and endogenous ROS but also peroxynitrite [10]. Final-
ly, it would be of interest to investigate whether expression
levels of mitochondrial PRDX5 depending on the cell type
could be linked to the vulnerability of mtDNA and whether
this is relevant for somatic mitochondrial diseases.
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